ECOG-ACRIN Cancer Research Group

Congratulations to Dr. Bob Gray of @HarvardChanSPH @DanaFarber on his retirement as @eaonc Group Statistician! 🎉 We’re grateful for his many contributions to the #CancerResearch community. Wishing him all the best in this next chapter!

Trial Activation: EA2251, led by Deirdre J. Cohen of @TischCancer @IcahnMountSinai, is a phase II/III randomized study of ivonescimab with gemcitabine and cisplatin versus standard of care #Chemoimmunotherapy in Advanced #BiliaryTract Cancer. More info: bit.ly/ea2251-study

#ClinicalTrial MM1OA-EA02, led by @jaltmanmd of @LurieCancer, aims to improve results for older adults with #AcuteMyeloidLeukemia (#AML). Learn more: bit.ly/mm1oa-ea02-stu… #BloodCancer #leukemia

Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: bit.ly/gable-trial

Do you have newly diagnosed #MultipleMyeloma and are either ineligible for or willing to delay #StemCell transplantation? If so, you may be eligible to participate in #ClinicalTrial EAA181/EQUATE. More info here: bit.ly/eaa181equate #MMSM #NDMM cc: @MM_Hub, @theMMRF